Receptor-activating peptides distinguish thrombin receptor (PAR-1) and protease activated receptor 2 (PAR-2) mediated hemodynamic responses in vivo

Canadian Journal of Physiology and Pharmacology

Volumn 76, Issue 1, 1998, Pages 16-25

  Cheung, Walman ^a   Andrade Gordon, Patricia ^a   Derian, Claudia K ^a   Damiano, Bruce P ^a  

^a R W JOHNSON PHARMACEUTICAL RES I   (United States)

Author keywords

Arterial pressure; Protease activated receptor; Protease activated receptor 2 (PARE 2); Thrombin receptor

Indexed keywords

ACETYLCHOLINE; GUANINE NUCLEOTIDE BINDING PROTEIN; N(G) NITROARGININE METHYL ESTER; PROTEINASE; PROTEINASE ACTIVATED RECEPTOR 2; SYNTHETIC PEPTIDE; THROMBIN RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL PRESSURE; ARTICLE; CELL FUNCTION; CONTROLLED STUDY; DOSE RESPONSE; HEART RATE; HEMODYNAMICS; INTRAVENOUS DRUG ADMINISTRATION; MALE; MEAN ARTERIAL PRESSURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; VASOMOTOR REFLEX;

EID: 0031919771     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/y97-176     Document Type: Article

References (44)

1. 2, in rat vascular and gastric smooth muscle. Can. J. Physiol. Pharmacol. 73: 1203-1207.
2. Antonaccio, M.J., Normandin, D., Serafino, R., and Moreland, S. 1993. Effects of thrombin and thrombin receptor activating peptides on rat aortic vascular smooth muscle. J. Pharmacol. Exp. Ther. 266: 125-132.
3. Badimon, L., Badimon, J.J., Galvez, A., Chesebro, J.H., and Fuster, V. 1986. Influence of arterial damage and wall shear rate on platelet deposition. Ex vivo study in a swine model. Arteriosclerosis, 6: 312-320.
4. Barrett, M.L., Willis, A.L., and Vane, J.R. 1989. Inhibition of platelet-derived mitogen release by nitric oxide (EDRF). Agents Actions, 27: 488-491.
5. Blackhart, B.D., Emilsson, K., Nguyen, D., Teng, W., Martelli, A.J., Nystedt, S., Sundelin, J., and Scarborough, R.M. 1996. Ligand cross-reactivity within the protease-activated receptor family. J. Biol. Chem. 271: 16466-16471.
6. Caughey, G.H. 1994. Serine proteinases of mast cell and leukocyte granules. A league of their own. [Review]. Am. J. Respir. Crit. Care Med. 150: S138-S142.
7. Connolly, T.M., Condra, C., Feng, D.-M., Cook, J.J., Stranieri, M.T., Reilly, C.F., Nutt, R.F., and Gould, R.J. 1994. Species variability in platelet and other cellular responsiveness to thrombin receptor-derived peptides. Thromb. Haemostasis, 72: 627-633.
8. Damiano, B.P., Cheung, W.M., Mitchell, J.A., and Falotico, R. 1996a. Cardiovascular actions of thrombin receptor activation in vivo. J. Pharmacol. Exp. Ther. 279: 1365-1378.
9. Damiano, B.P., Mitchell, J.A., Cheung, W.M., and Falotico, R. 1996b. Activation of vascular thrombin receptors mediates cardiac response to alpha-thrombin in isolated, perfused guinea pig heart. Am. J. Physiol. 39: H1585-H1596.
10. Derian, C.K., Santulli, R.J., Tomko, K.A., Haertlein, B.J., and Andrade-Gordon, P. 1995. Species differences in platelet responses to thrombin and SFLLRN. Receptor-mediated calcium mobilization and aggregation, and regulation by protein kinases. Thromb. Res. 78: 505-519.
11. Ehringer, W.D., Edwards, M.J., and Miller, F.N. 1996. Mechanisms of alpha-thrombin, histamine, and bradykinin induced endothelial permeability. J. Cell Physiol. 167: 562-569.
12. Emilsson, K., Wahlestedt, C., Sun, M.K., Nystedt, S., Owman, C., and Sundelin, J. 1997. Vascular effects of proteinase-activated receptor 2 agonist peptide. J. Vase. Res. 34: 267-272.
13. 2+ mobilization, barrier dysfunction, prostaglandin synthesis, and platelet-derived growth factor messenger RNA expression in cultured endothelium. J. Cell Physiol. 156: 541-549.
14. Garg, U.C., and Hassid, A. 1989. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J. Clin. Invest. 83: 1774-1777.
15. Godin, D., Marceau, F., Beaule, C., Rioux, F., and Drapeau, G. 1994. Aminopeptidase modulation of the pharmacological responses to synthetic thrombin receptor agonists. Eur. J. Pharmacol. 253: 225-230.
16. Gurwitz, D., and Cunningham, D.D. 1988. Thrombin modulates and reverses neuroblastoma neurite outgrowth. Proc. Natl. Acad. Sci. U.S.A. 85: 3440-3444.
17. Haertlein, B.J., Mitchell, J.A., Andrade-Gordon, P., Falotico, R., and Damiano, B.P. 1996. Protease-activated receptor-2 does not mediate the actions of thrombin or SFLLRN in coronary vasculature. FASEB J. 10: A41.
18. Haver, V.M., and Namm, D.H. 1984. Characterization of the thrombin-induced contraction of vascular smooth muscle. Blood Vessels, 21: 53-63.
19. Hwa, J.J., Ghibaudi, L., Williams, P., Chintala, M., Zhang, R.M., Chatterjee, M., and Sybertz, E. 1996. Evidence for the presence of a proteinase-activated receptor distinct from the thrombin receptor in vascular endothelial cells. Circ. Res. 78: 581-588.
20. Ishihara, H., Connolly, A.J., Zeng, D., Kahn, M.L., Zheng, Y.W., Timmons, C., Tram, T., and Coughlin, S.R. 1997. Protease-activated receptor 3 is a second thrombin receptor in humans. Nature (London), 386: 502-506.
21. Ku, D.D. 1986, Mechanism of thrombin-induced endothelium-dependent coronary vasodilation in dogs: role of its proteolytic enzymatic activity. J. Cardiovasc. Pharmacol. 8: 29-36.
22. Ku, D.D., and Zaleski, J.K. 1993. Receptor mechanism of thrombin-induced endothelium-dependent and endothelium-independent coronary vascular effects in dogs. J. Cardiovasc. Pharmacol. 22: 609-616.
23. Lerner, D.J., Chen, M., Tram, T., and Coughlin, S.R. 1996. Agonist recognition by proteinase-activated receptor 2 and thrombin receptor - importance of extracellular loop interactions for receptor function. J. Biol. Chem. 271: 13943-13947.
24. Lum, H., Andersen, T.T., Fenton, J.W., II, and Malik, A.B. 1994. Thrombin receptor activation peptide induces pulmonary vasoconstriction. Am. J. Physiol. 266: C448-C454.
25. Magazine, H.I., Butt, O., and Yaghoutiel, H.R. 1996. Endothelin and nitric oxide release modulate aortic contraction to selected thrombin receptor agonists. Am. J. Physiol. 39: C1815-C1818.
26. McNamara, C.A., Sarembock, I.J., Gimple, L.W., Fenton, J.W., II, Coughlin, S.R., and Owens, G.K. 1993. Thrombin stimulates proliferation of cultured rat aortic smooth muscle cells by a proteolytically activated receptor. J. Clin. Invest. 91: 94-98.
27. Minnear, F.L., DeMichele, M.A., Leonhardt, S., Andersen, T.T., and Teitler, M. 1993. Isoproterenol antagonizes endothelial permeability induced by thrombin and thrombin receptor peptide. J. Appl. Physiol. 75: 1171-1179.
28. Mirza, H., Yatsula, V., and Bahou, W.F. 1996. The proteinase-activated receptor-2 (PAR-2) mediates mitogenic responses in human vascular endothelial cells - molecular characterization and evidence for functional coupling to the thrombin receptor. J. Clin. Invest. 97: 1705-1714.
29. Muramatsu, I., Laniyonu, A., Moore, G.J., and Hollenberg, M.D. 1992. Vascular actions of thrombin receptor peptide. Can. J. Physiol. Pharmacol. 70: 996-1003.
30. Nagao, T., and Vanhoutte, P.M. 1992. Hyperpolarization as a mechanism for endothelium-dependent relaxations in the porcine coronary artery. J. Physiol. (London), 445: 355-367.
31. Nelken, N.A., Soifer, S.J., O'Keefe, J., Vu, T.-K.H., Charo, I.F., and Coughlin, S.R. 1992. Thrombin receptor expression in normal and atherosclerotic human arteries. J. Clin. Invest. 90: 1614-1621.
32. Nystedt, S., Emilsson, K., Wahlestedt, C., and Sundelin, J. 1994. Molecular cloning of a potential proteinase-activated receptor. Proc. Natl. Acad. Sci. U.S.A. 91: 9208-9212.
33. Nystedt, S., Ramakrishnan, V., and Sundelin, J. 1996. The proteinase-activated receptor-2 is induced by inflammatory mediators in human endothelial cells. Comparison with the thrombin receptor. J. Biol. Chem. 271: 14910-14915.
34. Pinheiro, J.M.B., Andersen, T.T., and Malik, A.B. 1993. Receptor mechanism of thrombin-mediated pulmonary vasodilation in neonates. Am. J. Physiol. 265: L355-L359.
35. Rapoport, R.M., Draznin, M.B., and Murad, F. 1984. Mechanisms of adenosine triphosphate-, thrombin-, and trypsin-induced relaxation of rat thoracic aorta. Circ. Res. 55: 468-479.
36. 2+ mobilization. FEBS Lett. 288: 123-128.
37. Soifer, S.J., Peters, K.G., O'Keefe, J., and Coughlin, S.R. 1994. Disparate temporal expression of the prothrombin and thrombin receptor genes during mouse development. Am. J. Pathol. 144: 60-69.
38. Sower, L.E., Froelich, C.J., Carney, D.H., Fenton, J.W., and Klimpel, G.R. 1995. Thrombin induces IL-6 production in fibroblasts and epithelial cells - evidence for the involvement of the seven-transmembrane domain (STD) receptor for alpha-thrombin. J. Immunol. 155: 895-901.
39. Taylor, S.G., Southerton, J.S., Weston, A.H., and Baker, J.R. 1988. Endothelium-dependent effects of acetylcholine in rat aorta: a comparison with sodium nitroprusside and cromakalim. Br. J. Pharmacol. 94: 853-863.
40. Tesfamariam, B., Allen, G.T., Normandin, D., and Antonaccio, M.J. 1993. Involvement of the tethered ligand receptor in thrombin-induced endothelium-mediated relaxations. Am. J. Physiol. 265: H1744-H1749.
41. Vu, T.-K.H., Hung, D.T., Wheaton, V.I., and Coughlin, S.R. 1991. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell, 64: 1057-1068.
42. Walz, D.A., Anderson, G.F., Ciaglowski, R.E., Aiken, M., and Fenton, J.W., II. 1985. Thrombin-elicited contractile responses of aortic smooth muscle. Proc. Soc. Exp. Biol. Med. 180: 518-526.
43. White, R.P., Shirasawa, Y., and Robertson, J.T. 1984. Comparison of responses elicited by alpha-thrombin in isolated canine basilar, coronary, mesenteric, and renal arteries. Blood Vessels, 21: 12-22.
44. Wilcox, J.N., Rodriguez, J., Subramanian, R., Ollerenshaw, J., Zhong, C.Z., Hayzer, D.J., Horaist, C., Hanson, S.R., Lumsden, A., Salam, T.A., Kelly, A.B., Harker, L.A., and Runge, M. 1994. Characterization of thrombin receptor expression during vascular lesion formation. Circ. Res. 75: 1029-1038.